A recent study investigating outpatient antibiotic use has highlighted a critical need for enhanced clinical oversight, ...

The Segunda RFEF match between Torrent CF and CD Castellón B, set for Sunday 12:00 at San Gregorio, was postponed by the RFEF ...

Interna Therapeutics, a clinical-stage biopharmaceutical company announced today that it has signed an agreement with the University of Oxford to conduct a Phase IIa human challenge trial evaluating ...

Apogee Therapeutics (NASDAQ:APGE) shares rose 15% Monday following positive 52-week data from Part A of its Phase 2 APEX ...

Ivarmacitinib is associated with favorable treatment outcomes in patients with moderate to severe AD across subgroups with diverse characteristics.

Tuberculosis can recur through relapse or new drug-resistant strains, often triggered by incomplete treatment, a weakened ...

APEX Part A data demonstrated durable maintenance of response at 52-weeks for every 3- and 6-months dosing, respectively, including:- 75% and 85% ...

APEX Part A data demonstrated durable maintenance of response at 52-weeks for every 3- and 6-months dosing, respectively, including: ...

Shares of Apogee Therapeutics (NASDAQ:APGE) jumped 15% on Monday after the company reported positive 52-week results from ...

Scientists have proven that a wildflower steeped in folklore for its medicinal powers has genuine healing qualities—and the ...

India, March 23 -- Antimicrobial resistance (AMR) is one of the most serious global health challenges, directly responsible ...

When most people hear the word tuberculosis (TB), they usually think of a lung disease that causes persistent cough and fever ...